![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lucioni C.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.13, Iss.2, 1998-02, pp. : 257-266
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cost of epilepsy variable in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Searching for cost-effective options in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HAART introduction in Italy provides cost, QOL advantage
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Primary prevention of CVD with aspirin cost saving in Italy
Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. :